Pooled analysis on characteristics of nausea and vomiting in patients receiving trastuzumab deruxtecan (T-DXd) in clinical studies

被引：0
|
作者：
Park, Yeon Hee
Cortes, Javier
Modi, Shanu
Hurvitz, Sara A.
Bianchini, Giampaolo
Iwata, Hiroji
Shitara, Kohei
Siena, Salvatore
Goto, Yasushi
Ku, Geoffrey Yuyat
Charles, Powell Andrew
Swain, Sandra M.
Arunachalam, Meena
Janek, Martin
Cheng, Yingkai
Chu, Changan
Verma, Purnima
Mathias, Elton
Karnoub, Maha
Rugo, Hope S.
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Quironsalud Grp, IBCC, Pangaea Oncol, Barcelona, Spain
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Univ Washington, Sch Med, Seattle, WA USA
[5] Fred Hutchinson Canc Ctr, Seattle, WA USA
[6] Univ Vita Salute San Raffaele, Milan, Italy
[7] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[8] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[9] Univ Milan, Milan, Italy
[10] Niguarda Canc Ctr, Milan, Italy
[11] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan
[12] Tisch Canc Inst, Mt Sinai Hosp, New York, NY USA
[13] Georgetown Univ, Washington, DC USA
[14] Daiichi Sankyo Inc, Basking Ridge, NJ USA
[15] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12118
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Financial toxicity in patients with metastatic breast cancer on trastuzumab deruxtecan (T-DXd)
    Lapen, Kaitlyn
    Dee, Edward Christopher Christopher
    Thom, Bridgette
    Aviki, Emeline Mariam
    Chino, Fumiko
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Predictors of resistance to trastuzumab deruxtecan (T-DXd) in esophagogastric adenocarcinoma (EGC)
    Tsai, Charlton
    Chou, Joanne F.
    de Castria, Tiago Biachi
    Tang, Laura H.
    Ilson, David H.
    Ku, Geoffrey Yuyat
    Schultz, Nikolaus
    Capanu, Marinela
    Janjigian, Yelena Y.
    Maron, Steven Brad
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective
    Henning, Jan-Willem
    Brezden-Masley, Christine
    Gelmon, Karen
    Chia, Stephen
    Shapera, Shane
    Mcinnis, Micheal
    Rayson, Daniel
    Asselah, Jamil
    CURRENT ONCOLOGY, 2023, 30 (09) : 8019 - 8038
  • [4] Impact of HER2 Expression on trastuzumab deruxtecan(T-DXd) efficacy
    Chen, Wanyi
    Drago, Joshua
    Gupta, Avantika
    Liu, Bo
    Chandarlapaty, Sarat
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Adverse effects (AEs) of trastuzumab deruxtecan (T-DXd) in solid tumours: A meta-analysis
    Pathak, N.
    Di Iorio, M. R.
    Savill, J.
    Wygoda, Y. Berner
    Gimenez, D. Malon
    Li, M.
    Valiente, C. Molto
    Nadler, M.
    Mittal, A.
    Amir, E.
    ANNALS OF ONCOLOGY, 2024, 35 : S1099 - S1100
  • [6] Pooled analysis of drug-related interstitial lung disease (ILD) in 8 single-arm trastuzumab deruxtecan (T-DXd) studies.
    Powell, Charles A.
    Modi, Shanu
    Iwata, Hiroji
    Takahashi, Shunji
    Smit, Egbert F.
    Siena, Salvatore
    Chang, Dwan-Ying
    Fuchs, Charles S.
    Nie, Kun
    Qin, Amy
    Singh, Jasmeet
    Taitt, Corina
    Verma, Sunil
    Camidge, D. Ross
    CANCER RESEARCH, 2021, 81 (13)
  • [7] Trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment
    Tarantino, P.
    Tolaney, S. M.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2023, 34 (10) : 949 - 950
  • [8] PHARMACOKINETICS OF TRASTUZUMAB DERUXTECAN (T-DXD) IN SUBJECTS WITH HER2-LOW METASTATIC BREAST CANCER
    Lu, Z.
    Hennig, S.
    Li, L.
    Kamiyama, E.
    Vaddady, P.
    Abutarif, M.
    Garimella, T.
    Khatri, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S93 - S94
  • [9] Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
    Tsao, Li-Chung
    Wang, John S.
    Ma, Xingru
    Sodhi, Sirajbir
    Ragusa, Joey V.
    Liu, Bushangqing
    McBane, Jason
    Wang, Tao
    Wei, Junping
    Liu, Cong-Xiao
    Yang, Xiao
    Lei, Gangjun
    Spasojevic, Ivan
    Fan, Ping
    Trotter, Timothy N.
    Morse, Michael
    Lyerly, Herbert Kim
    Hartman, Zachary C.
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [10] Unraveling the mechanism of action and resistance to trastuzumab deruxtecan (T-DXd): Biomarker analyses from patients from DAISY trial
    Mosele, M. F.
    Lusque, A.
    Dieras, V. C.
    Deluche, E.
    Ducoulombier, A.
    Pistilli, B.
    Bachelot, T.
    Viret, F.
    Levy, C.
    Pradat, Y. C.
    Tran, D. T. N.
    Droin, N.
    Kobayashi, M.
    Kakewaga, T.
    Deloger, M.
    Job, B.
    Jimenez, M.
    Lacroix-Triki, M.
    Andre, F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1440 - S1440
12345